This report analyses the underlying causes of China's achievements and gaps in universal
health coverage over the past 2 decades and proposes policy recommendations for …

Abstract Purpose of Review The introduction of the National Free Antiretroviral Therapy
Program (NFATP) in 2003 by the China National Center for AIDS/STD Control and …

Background Overall HIV mortality rates in China have not been reported. In this analysis we
assess overall mortality in treatment-eligible adults with HIV and attempt to identify risk …

Background: China's National Free Antiretroviral Treatment Program began in 2002 and, by
August 2008, included more than 52 000 patients. Objective: To report 5-year outcomes on …

Background The emergence and spread of HIV-1 drug resistance may compromise HIV
control globally. In response to HIV/AIDS epidemic, China launched national HIV/AIDS …

Background Clinical trials have demonstrated that immediate initiation of antiretroviral
therapy (ART) reduces AIDS-related morbidity and mortality. We tested the hypothesis that …

Abstract Background. In China, many former plasma donors were infected with the human
immunodeficiency virus (HIV) in the early–mid-1990s. Highly active antiretroviral therapy …

Introduction Social disruption associated with coronavirus disease 2019 (COVID‐19)
threatens to impede access to regular healthcare, including for people living with HIV …

Background HIV-related opportunistic infections (OIs) and malignancies continued to cause
morbidity and mortality in Chinese HIV-infected individuals. The objective for this study is to …

Mycobacterium tuberculosis is the most common opportunistic infection among patients with
human immunodeficiency virus (HIV) infection, and it is also the leading cause of death …